GFAP and Alzheimer disease: Within AD participants, the cluster analysis also yielded two groups (see Supplementary Material Fig. 2 with the distribution of CAI according to each cluster), presenting differences in plasma GFAP levels (p-value = 0.035) (Fig. 4B).